Is BKNG a buy, hold, or sell?
BKNG carries a valuation grade of Strong Buy. At a trailing P/E of 21.2, the stock trades at a 18% discount to the Consumer Cyclical sector median of 26.0x. Our discounted cash flow model produces an intrinsic range of $169–$293 — implying a +44% margin of safety at the current price of $160.64. The width of the DCF range reflects genuine uncertainty in the terminal growth rate assumption: the correct framework is a probability-weighted distribution over scenarios, not a single point estimate. See the DCF valuation framework for full methodology.
With a 12% beat rate on recent quarters, earnings predictability has been mixed. The most recent quarter delivered a 5.7% earnings surprise. Analyst estimate revisions are trending upward.
What are BKNG's key risk factors?
With a beta of 1.09, BKNG exhibits a market-neutral risk profile relative to the broad market. The 95th-percentile CVaR of -23.7% on a one-month horizon should inform position sizing directly: at a 10% portfolio weight, this tail event contributes approximately 2.4% of total portfolio loss in the worst 5% of months. Net margins of 22.2% are significantly above the Consumer Cyclical sector average of 10%, reflecting durable pricing power.
At 0.00, the put/call ratio skews bullish, with call buyers dominating recent flow. Implied volatility of 3.4% is below realized volatility of 26.1%, potentially making options relatively cheap. Insiders have been net sellers to the tune of $88.2M recently. While routine dispositions are common, the magnitude bears watching. Short interest is low at 3.1% of float, suggesting limited bearish conviction.
How does BKNG fit in a diversified portfolio?
At typical HENRY portfolio weights — 10–20% of the equity allocation — BKNG carries a beta of 1.09, meaning it amplifies broad market moves proportionally. The appropriate weight is not a function of conviction alone, but of the full covariance structure across all holdings. See the Ledoit-Wolf covariance framework for the methodology behind these calculations.
Among closely correlated names, BKNG shows the strongest co-movement with AMZN (0.29), META (0.25), RACE (0.21). Investors seeking diversification should note these correlation dynamics when constructing multi-asset portfolios.
True portfolio risk is a function of the full covariance structure across all holdings — not individual stock metrics. The Portfolio Health Check quantifies this at the portfolio level: it surfaces hidden concentration, marginal CVaR contributions, and the degree to which your overall allocation deviates from an optimal risk-adjusted mandate. The BKNG analysis here is a single node in that larger structure.
For the portfolio construction framework underpinning BKNG’s position sizing and conviction rating — including IPS guardrails, Black-Litterman allocation, and CVaR constraints — see: Investment Policy Statement Framework →
